TMEM97 and neoplasm: After adjusting for estimated tumor proliferation rates, PGRMC1, TMEM97, and TK1 were not associated with relapse-free survival (HR = 1.02; 95% CI = 0.91–1.14; HR = 1.04; 95% CI = 0.92–1.18; and HR = 1.05; 95% CI = 0.95–1.15, respectively; Figs. 2C and 3C; Supplementary Fig. S4].